Literature DB >> 8448931

Early migration of acetabular components revised with cement. A roentgen stereophotogrammetric study.

H Franzén1, B Mjöberg, R Onnerfält.   

Abstract

Roentgen stereophotogrammetric analysis (RSA) was used to evaluate the migration in 17 cemented acetabular components after revision operations for mechanical loosening. All of the hips were examined four months and one year after surgery; ten of the hips were also examined after two years. In 15 of the 17 components, definite migration (0.5-2.7 mm) was identified, whereas two acetabular components showed no significant migration (< 0.25 mm). In 13 hips, the migration was seen within four months after surgery. There was a tendency for larger migration in revisions for severe bone destruction. These findings indicate that prosthetic fixation in revision operations is relatively poor. In cases with severe bone loss, cement fixations is extremely poor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8448931

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  4 in total

Review 1.  How do tissues respond and adapt to stresses around a prosthesis? A primer on finite element stress analysis for orthopaedic surgeons.

Authors:  Richard A Brand; Clark M Stanford; Colby C Swan
Journal:  Iowa Orthop J       Date:  2003

2.  Metal backing improves the survival of surface replacement of the hip.

Authors:  H Franzén; B Mjöberg; U Rydholm
Journal:  Arch Orthop Trauma Surg       Date:  1993       Impact factor: 3.067

3.  Tantalum Components in Difficult Acetabular Revisions Have Good Survival at 5 to 10 Years: Longer Term Followup of a Previous Report.

Authors:  Paul F Lachiewicz; Jane Anne O'Dell
Journal:  Clin Orthop Relat Res       Date:  2018-02       Impact factor: 4.176

4.  Tantalum augments for Paprosky IIIA defects remain stable at midterm followup.

Authors:  Daniel J Del Gaizo; Vamsi Kancherla; Scott M Sporer; Wayne G Paprosky
Journal:  Clin Orthop Relat Res       Date:  2012-02       Impact factor: 4.176

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.